i-Stitch for Bilateral Sacrospinous Ligament Fixation (SSLF)
i-StitchSSLF
1 other identifier
observational
100
1 country
1
Brief Summary
The purpose of the clinical investigation is to generate clinical data to substantiate the safety and performance of the i-Stitch device for bilateral sacrospinous ligament fixation (SSLF) in pelvic organ prolapse (POP) repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
March 20, 2026
March 1, 2026
1.6 years
January 28, 2025
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Subjective outcome
German Pelvic Floor Questionnaire ("Deutscher Beckenboden-Fragebogen")
12 months
Subjective outcome
German Pelvic Floor Questionnaire ("Deutscher Beckenboden-Fragebogen")
3 months
Secondary Outcomes (3)
Quality of life (ICIQ-UI SF)
12 months
Postoperative complications
12 months
Anatomical outcome (POP-Q)
12 months
Interventions
Bilateral sacrospinous ligament fixation with i-Stitch device
Eligibility Criteria
Patients with symptomatic pelvic organ prolapse indicated for a surgical intervention.
You may qualify if:
- Surgery for POP
- SSLF with usage of i-Stitch device (\& i-Stitch Loading Units)
- Concomitant procedures are allowed
- Women minimum 18 years old
- Written informed consent for surgery
You may not qualify if:
- infection (active or latent)
- allergies to the materials used
- benign or malignant changes
- anticoagulation disorders
- autoimmune connective tissue disorders
- any uterus pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Isar Kliniken GmbH
Munich, Bavaria, 80331, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ursula Peschers, Prof. Dr.
ISAR Klinikum Munich
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 3, 2025
Study Start
January 1, 2025
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share